View Clinical Trial (Medical Research Study)
A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids - NCT00930163-35209(Clinical Trial 350865)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Birmingham |
|
State:
|
|
AL |
| Zip Code: |
|
35209 |
| Conditions: |
|
Asthma |
| Purpose: |
|
This is a randomized, double-blind, placebo-controlled study to evaluate the effects of
lebrikizumab in patients with asthma who remain inadequately controlled while on chronic
therapy with inhaled corticosteroids (ICS).
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Body weight 40 kg--150 kg
- Chest radiograph with no evidence of clinically significant abnormality
- Uncontrolled asthma
Exclusion Criteria:
- Asthma exacerbation during screening
- Known malignancy
- Known immunodeficiency
- Pre-existing lung disease other than asthma
- Uncontrolled clinically significant medical disease
- Current smoker
- History of substance abuse that may impair or risk the patient's full participation
in the study, in the judgment of the investigator
- Prior allergic reaction to a monoclonal antibody
- Patients (men and women) of reproductive potential who are not willing to use
contraception
- Pregnancy |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|